NYCOMED GMBH

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
C07K PEPTIDES 3133
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 3164
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 297
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 1254
 
  
 
B65D CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES 197
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 198

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
5876970 Surfactant compositions and methodsJul 21, 94Mar 02, 99[C07H, C12P, C07K]
5840527 Recombinant alveolar surfactant proteinJun 07, 95Nov 24, 98[C12N]
5430020 Recombinant alveolar surfactant proteinJun 09, 93Jul 04, 95[C07K]
5403915 Isolation and purification of lung surfactant proteinAug 18, 93Apr 04, 95[C07K]
5385840 DNA encoding analogs of human alveolar surfactant protein SP-5Oct 23, 92Jan 31, 95[C12N]
5352681 Pharmaceutical enema preparationDec 07, 93Oct 04, 94[A61K, B65D]
5169761 DNA encoding and expression systems for alveolar surfactant proteinsMay 14, 91Dec 08, 92[C12P, C12N]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2011/0136,803 TriazolophthalazinesAbandonedNov 05, 09Jun 09, 11[A61K, A61P]
2011/0044,938 TETRAHYDROBENZOTHIOPHENE DERIVATIVESAbandonedAug 15, 07Feb 24, 11[A61K, C07D, A61P]
2010/0317,650 IMIDAZOPYRIDINE DERIVATIVES USEFUL AS INOS INHIBITORSAbandonedAug 03, 10Dec 16, 10[A61K, A61P]
2010/0286,140 TRIAZOLOPHTHALAZINESAbandonedApr 23, 10Nov 11, 10[A61K, A61P]
2010/0234,382 COMPOSITION COMPRISING A PDE4 INHIBITOR AND A PDE5 INHIBITORAbandonedMay 24, 10Sep 16, 10[A61K, A61P]
7790710 Imidazopyridine derivatives useful as iNOS inhibitorsExpiredMar 29, 06Sep 07, 10[A61K, A01N, C07D]
2010/0179,131 Combination treatment for diabetes mellitusAbandonedSep 04, 07Jul 15, 10[A61K, A61P]
2010/0120,730 6-BENZYL-2,3,4,7-TETRAHYDRO-INDOLO [2,3-C] QUINOLINE COMPOUNDS USEFUL AS PDE5 INHIBITORSAbandonedJan 30, 08May 13, 10[A61K, C07D, A61P]
7671068 N-(alkoxyalkyl) carbamoyl-substituted 6-phenyl-benzonaphthyridine derivatives and their use as PDE ¾ inhibitorsExpiredMar 16, 05Mar 02, 10[A61K, A01N, C07D]
2009/0298,108 Method for Identifying PDE11 ModulatorsAbandonedMay 18, 05Dec 03, 09[C12Q, C12P, C12N]
2009/0246,169 INDOLOPYRIDINES AS EG5 KINESIN MODULATORSAbandonedFeb 21, 07Oct 01, 09[A61K, C07D, A61P]
2009/0209,591 Pharmaceutical product for injectionAbandonedApr 27, 09Aug 20, 09[A61K]
2009/0170,125 Cellular assay method for identifying pkc-0 inhibitorsAbandonedApr 27, 06Jul 02, 09[C12Q, G01N, C07K]
2009/0134,211 MethodAbandonedJun 08, 06May 28, 09[G06K]
2009/0093,473 Spiro-benzimidazoles as inhibitors of gastric acid secretionAbandonedJun 13, 06Apr 09, 09[A61K, C07D, A61P]
2009/0087,871 Method for Identifying PDE5-ModulatorsAbandonedMay 18, 05Apr 02, 09[C12N]
2009/0030,065 Use of Pde1c and Inhibitors ThereofAbandonedJun 13, 06Jan 29, 09[A61K, G01N]
2009/0020,442 Method for the Provision of Clinical Trial ProductsAbandonedJun 08, 06Jan 22, 09[B65D]
2009/0011,978 Use of Surfactant Preparations for the Treatment of Surgical AdhesionsAbandonedAug 27, 04Jan 08, 09[A61K, A61P]
2008/0280,855 Process For the Production of Intermediates For the Preparation of Tricyclic BenzimidazolesAbandonedJun 20, 06Nov 13, 08[A61K, C07F, C07D]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.